BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30110620)

  • 1. Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy.
    Mori Y; Takahashi M; Ohno Y; Okura R; Ishida M; Higashi T; Motoyama K; Arima H
    Int J Pharm; 2018 Oct; 549(1-2):456-465. PubMed ID: 30110620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical and practical evaluation of lowly hydrolyzed polyvinyl alcohol as a potential carrier for hot-melt extrusion.
    Mori Y; Motoyama K; Ishida M; Onodera R; Higashi T; Arima H
    Int J Pharm; 2019 Jan; 555():124-134. PubMed ID: 30448311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive understanding of lowly-hydrolyzed polyvinyl alcohol-based ternary solid dispersions with the use of a combined mixture-process design.
    Mori Y; Higashi T; Motoyama K; Ishida M; Onodera R; Arima H
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1599-1609. PubMed ID: 31271320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
    Prasad D; Chauhan H; Atef E
    Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Insight into Stabilization Mechanism of a Solid Dispersion of Indomethacin/Partially Hydrolyzed Polyvinyl Alcohol Prepared by Hot-Melt Extrusion.
    Benjasirimongkol P; Ueda K; Higashi K; Sriamornsak P; Moribe K
    Chem Pharm Bull (Tokyo); 2018; 66(9):859-865. PubMed ID: 30175742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR investigation of a novel excipient, α-glucosylhesperidin, as a suitable solubilizing agent for poorly water-soluble drugs.
    Zhang J; Tozuka Y; Uchiyama H; Higashi K; Moribe K; Takeuchi H; Yamamoto K
    J Pharm Sci; 2011 Oct; 100(10):4421-31. PubMed ID: 21604275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gummi Formulations Comprising Amenamevir Solid Dispersions with Polyvinyl Alcohol.
    Umemoto Y; Tanaka S; Kambayashi A; Sugimoto K; Kashiwagura Y; Namiki N; Uchida S
    Chem Pharm Bull (Tokyo); 2021; 69(9):862-871. PubMed ID: 34470950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of triacetin effect on indomethacin release from poly(methyl methacrylate) microspheres: evaluation of interactions using FT-IR and NMR spectroscopies.
    Yuksel N; Baykara M; Shirinzade H; Suzen S
    Int J Pharm; 2011 Feb; 404(1-2):102-9. PubMed ID: 21093553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hydrophilic/hydrophobic group ratio of polyvinyl alcohol on the miscibility of amlodipine in orodispersible films: From molecular mechanism study to product attributes.
    Liu J; Zhang Y; Li H; Liu C; Quan P; Fang L
    Int J Pharm; 2023 Jan; 630():122383. PubMed ID: 36370996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
    Patel DD; Joguparthi V; Wang Z; Anderson BD
    J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
    Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
    Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug solubilization mechanism of α-glucosyl stevia by NMR spectroscopy.
    Zhang J; Higashi K; Ueda K; Kadota K; Tozuka Y; Limwikrant W; Yamamoto K; Moribe K
    Int J Pharm; 2014 Apr; 465(1-2):255-61. PubMed ID: 24508331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisolvent precipitation of novel xylitol-additive crystals to engineer tablets with improved pharmaceutical performance.
    Kaialy W; Maniruzzaman M; Shojaee S; Nokhodchi A
    Int J Pharm; 2014 Dec; 477(1-2):282-93. PubMed ID: 25447824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polymerization and hydrolysis degrees of poly(vinyl alcohol) (PVA) on the efficiency of the PVA-solid substrate for room-temperature phosphorimetry.
    Kitade T; Wada Y; Takegami S; Kuroda A; Kishi S; Kitamura K
    Anal Sci; 2002 Mar; 18(3):337-41. PubMed ID: 11918196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
    Kushida I; Gotoda M
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.
    Wlodarski K; Zhang F; Liu T; Sawicki W; Kipping T
    Pharm Res; 2018 Jan; 35(1):16. PubMed ID: 29305665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
    Brough C; Miller DA; Ellenberger D; Lubda D; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):180-90. PubMed ID: 26863889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.